Niagen Bioscience (NAGE) Non-Current Deferred Tax Liability (2016 - 2019)

Niagen Bioscience (NAGE) has reported Non-Current Deferred Tax Liability for 3 consecutive years, with $218000.0 the latest figure, recorded in Q4 2019.

• In Q4 2019, Non-Current Deferred Tax Liability rose 59.12% year-over-year to $218000.0; the TTM figure through Dec 2019 stood at $218000.0 (up 59.12% YoY), while the FY2019 annual figure was $218000.0, up 59.12% from the prior year.
• Non-Current Deferred Tax Liability advanced to $218000.0 in Q4 2019 per NAGE's latest filing, from $137000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $218000.0 in Q4 2019 and bottomed at $137000.0 in Q4 2018.
• Historically, Non-Current Deferred Tax Liability has averaged $166333.3 across 3 years, with a median of $144000.0 in 2017.
• Annual changes were most pronounced in 2018 — Non-Current Deferred Tax Liability declined 4.86% — and 2019, when it soared 59.12%.
• Niagen Bioscience's Non-Current Deferred Tax Liability stood at $144000.0 in 2017, then dropped by 4.86% to $137000.0 in 2018, then jumped by 59.12% to $218000.0 in 2019.
• Business Quant data shows NAGE's Non-Current Deferred Tax Liability at $218000.0 in Q4 2019, $137000.0 in Q4 2018, and $144000.0 in Q4 2017.